Hüseyin Tokgöz

Hüseyin Tokgöz

Auto-generated profile, based on publicly available information

Hüseyin Tokgöz

Department of Pediatric Hematology&Oncology, Necmettin Erbakan University Faculty of Medicine, Konya, Türkiye

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MOMasato Ogishi
Masato Ogishi
RYRui Yang
Rui Yang
RRRémy Rodriguez
Rémy Rodriguez
DGDominic P. Golec
Dominic P. Golec
EMEmmanuel Martin
Emmanuel Martin
SBStephanie Boisson-Dupuis
Stephanie Boisson-Dupuis
Inborn errors of IFN-γ immunity can underlie tuberculosis (TB). We report three patients from two kindreds without EBV viremia or disease but with severe TB and inherited complete ITK deficiency, a condition associated with severe EBV disease that renders immunological studies challenging. They have CD4+ αβ T lymphocytopenia with a concomitant expansion of CD4−CD8− double-negative (DN) αβ and Vδ2− γδ T lymphocytes, both displaying a unique CD38+CD45RA+T-bet+EOMES− phenotype. Itk-deficient mice recapitulated an expansion of the γδ T and DN αβ T lymphocyte populations in the thymus and spleen, respectively. Moreover, the patients’ T lymphocytes secrete small amounts of IFN-γ in response to TCR crosslinking, mitogens, or forced synapse formation with autologous B lymphocytes. Finally, the patients’ total lymphocytes secrete small amounts of IFN-γ, and CD4+, CD8+, DN αβ T, Vδ2+ γδ T, and MAIT cells display impaired IFN-γ production in response to BCG. Inherited ITK deficiency undermines the development and function of various IFN-γ–producing T cell subsets, thereby underlying TB.

9 September 2022 in Balkan Medical Journal
Verified
Journal Article
Open access
MHMelih Hangül
Melih Hangül
MKMehmet Köse
Mehmet Köse
SPSevgi Pekcan
Sevgi Pekcan
ÜÇÜmran Çalışkan
Ümran Çalışkan
HTHüseyin Tokgöz
Hüseyin Tokgöz
AYAslı İmran Yılmaz
Aslı İmran Yılmaz
Pulmonary embolism is a clinical condition caused by the obstruction of the pulmonary artery and its branches with endogenous, exogenous embolism, or local thrombus formation. It is a rare but potentially life-threatening event in the pediatric population. Pediatric pulmonary embolism has many unknown characteristics. To evaluate clinical features, genetic and acquired risk factors, diagnostic imaging, and treatment strategies with long-term results in children with pulmonary embolism. A retrospective multicenter clinical trial. Patients aged 0-18 years who were diagnosed with pulmonary embolism with computed tomography pulmonary angiography (CTPA) findings (intraluminal filling defect in the lobar or main pulmonary artery) in 3 university hospitals between 2006 and 2021 were included in the study. A form was created for data standardization, and variables were collected retrospectively through medical record review. In addition to the features given above, we also evaluated in situ pulmonary artery thrombosis (ISPAT) and patients’ Wells scores. Follow-up CTPA results were evaluated for patient response to treatment. Complete recovery means that there were no lesions, incomplete recovery if there was still embolism, and no response if there was no change. Twenty-four patients (female:13, male:11) were included in the study. The mean age was 13.5 years. All patients but one had at least one or more genetic or acquired risk factors. Factor V Leiden mutation (16.6%) was the most common genetic risk factor. Six of 16 patients with Doppler ultrasonography were diagnosed with ISPAT because there was no sign of thromboembolic thrombosis. Nine (41.6%) patients had a Wells score of >4 (pulmonary embolism clinically strong), and 15 (58.4%) patients scored <4 (pulmonary embolism clinically likely weak), indicating that an alternative diagnosis was more likely than pulmonary embolism (sensitivity %37.5). The mean follow-up period was 23 (±17) months. Complete and incomplete recovery was observed in 15 (62.5%) and 7 (29.1%) patients, respectively, among the patients who underwent follow-up evaluation. No response was obtained in 2 patients (8.3%) who died. The Wells scoring system seems insufficient to diagnose pulmonary embolism in children and should be improved by adding new parameters. ISPAT may be more common in children with congenital heart disease and systemic disease.

2 June 2021 in Turkish Journal of Hematology
Verified
Journal Article
Open access
KKKaan Kavakli
Kaan Kavakli
SÖSüha Süreyya Özbek
Süha Süreyya Özbek
AAAli Bülent Antmen
Ali Bülent Antmen
FŞFahri Şahin
Fahri Şahin
ŞAŞevkiye Selin Aytaç
Şevkiye Selin Aytaç
BÖBurcu Özkan
Burcu Özkan
To observe preventive effect of prophylactic treatment on joint health in people with hemophilia (PwH) and to investigate the importance of integration of ultrasonographic examination into clinical and radiological evaluation of the joints. This national, multicenter, prospective, observational study included male patients aged ≥6 years with the diagnosis of moderate or severe hemophilia A or B from 8 centers across Turkey between January 2017-March 2019. Patients were followed-up for 1 year by 5 visits (baseline, 3rd, 6th, 9th, and 12th month visits). The Hemophilia Joint Health Score (HJHS) was used for physical examination of joints; the Pettersson Scoring was used for radiological assessment; Point-of-care (POC) ultrasonography was used for bilateral examinations of joints; and the Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) was used for evaluation of ultrasonography results. Seventy-three hemophilic patients, of whom 62 had hemophilia A and 11 had hemophilia B, were included and 24.7% had target joints at baseline. The HJHS and HEAD-US scores were significantly increased at the 12th month in all patients. These scores were also higher in the hemophilia A subgroup than the hemophilia B subgroup. However, in childhood group increment of scores were not significant. The HEAD-US total score was significantly correlated with both the HJHS total score and Pettersson total score at the baseline and 12th month. The HEAD-US and HJHS scoring systems are valuable tools during follow-up examinations of PwH and they complement each other. We suggested that POC Ultrasonographic evaluation and the HEAD-US scoring system may be integrated into differential diagnosis of bleeding and long-term monitoring for joint health as a routine procedure.

17 March 2020 in Turkish Journal of Hematology
Verified
Journal Article
Open access
AYAyça Koca Yozgat
Ayça Koca Yozgat
GLGöksel Leblebisatan
Göksel Leblebisatan
SASinan Akbayram
Sinan Akbayram
SÖSimge Çınar Özel
Simge Çınar Özel
ZKZeynep Karakaş
Zeynep Karakaş
NÖNamık Yaşar Özbek
Namık Yaşar Özbek
Objective: Immune thrombocytopenia (ITP) is a rare autoimmune disease and hematologic disorder characterized by reduced platelet counts that can result in significant symptoms, such as bleeding, bruising, epistaxis, or petechiae. The thrombopoietin receptor agonist eltrombopag (EPAG) is a second-line agent used to treat chronic ITP purpura in adults and children. Materials and Methods: The present retrospective study evaluated the efficacy, safety, and side effects of EPAG treatment in pediatric patients with acute refractory and chronic immune thrombocytopenia, particularly focusing on iron-deficiency anemia. Results: The diagnosis was chronic ITP in 89 patients and acute refractory ITP in 16 patients. The mean age of patients was 9.5 +/- 4.5 years (minimum-maximum: 1.2-18 years) at the beginning of EPAG treatment. The overall response rate was 74.3% (n=78). The mean time for platelet count of >= 50x109/L was 11.6 +/- 8 weeks (range: 1-34 weeks). The treatment was stopped for 27 patients (25.7%) at an average of 6.8 +/- 9 months (range: 1-38 months). The reason for discontinuation was lack of response in 18 patients, nonadherence in 4 patients, and hepatotoxicity in 2 patients. Response to treatment continued for an average of 4 months after cessation of EPAG in 3 patients. Conclusion: Results of the current study imply that EPAG is an effective therapeutic option in pediatric patients with acute refractory and chronic ITP. However, patients must be closely monitored for response and side effects during treatment, and especially for iron deficiency.

7 October 2024 in The Turkish Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
DKDilek Kaçar
Dilek Kaçar
RKRejin Kebudi
Rejin Kebudi
DÖDerya Özyörük
Derya Özyörük
DTDeniz Tuğcu
Deniz Tuğcu
ABAyşenur Bahadır
Ayşenur Bahadır
NYNeşe Yaralı
Neşe Yaralı
Background. Microbiologic confirmation of respiratory tract infections gained importance during the coronavirus disease 2019 (COVID-19) pandemic. This study retrospectively evaluated seasonal distribution, clinical presentation, and complications of respiratory viral infections (RVIs) other than COVID-19 in children with cancer during and after the pandemic lockdown. Methods. Two hundred and sixty-five inpatient and outpatient RVI episodes in 219 pediatric cancer patients confirmed by multiplex reverse transcriptase polymerase chain reaction (RT-PCR) panels from 13 centers were enrolled. Results. Eighty-six (32.5%) of the total 265 episodes occurred in 16 months corresponding to the lockdowns in Türkiye, and the remaining 67.5% in 10 months thereafter. Human rhinovirus/enterovirus (hRE) (48.3%) was the most common agent detected during and after lockdown. Parainfluenza virus (PIV) (23.0%), influenza virus (9.8%), and respiratory syncytial virus (RSV) (9.1%) were the other common agents. The 28.7% of episodes were lower respiratory tract infections (LRTIs), and complications and mortality were higher than upper respiratory tract infections (URTIs) (25.0% vs 5.3%). Bacteremia was identified in 11.5% of culture-drawn episodes. Treatment delay in one-third and death within four weeks after RVI in 4.9% of episodes were observed. Conclusion. During the pandemic, fewer episodes of RVIs occurred during the lockdown period. Respiratory viruses may cause complications, delays in treatment, and even death in children with cancer. Therefore, increased awareness of RVIs and rapid detection of respiratory viruses will benefit the prevention and, in some cases, abrupt supportive and some antiviral treatment of RVI in children with cancer.

5 July 2018 in Journal of Neonatal-Perinatal Medicine
Verified
Journal Article
Closed access
PDF file
NGN. Dilay Gültekin
N. Dilay Gültekin
MYMehmet Fatih Yılmaz
Mehmet Fatih Yılmaz
HAH. Altunhan
H. Altunhan
SFS. Findik
S. Findik
HTH. Tokgöz
H. Tokgöz
ÜÇÜmran Çalişkan
Ümran Çalişkan
Kasabach-Merritt syndrome is a rare life-threatening clinical presentation in neonatal period. it is characterized by giant hemangioma and serious thrombocytopenia. The diagnostic criteria include: 1) hemangiomas on skin, 2) thrombocytopenia or coagu